ALZN
Alzamend Neuro Inc
NASDAQHealthcareBiotechnologyUS
USD1.24
+0.08 (+6.90%)
Rating:C-
Company Profile
CEO
Stephan Jackman
IPO Date
2021-06-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.14
Prev. Close
$1.16
Day Low
$1.12
Day High
$1.24
52W Low
$0.84
52W High
$3.60
Market Cap
$0.00B
Volume
0.13M